title: LETTER TO THE EDITOR Screening for Fingolimod Associated Macular Oedema: Experience Versus Guidelines.
abstract: We report adherence to United Kingdom national guidelines on surveillance for Fingolimod associated macular oedema (FAME) and the impact on clinical services at our unit. We conducted a 9-month study, measuring referral interval, visual function and performing OCT scans for all patients referred for FAME surveillance. 38 patients in total were seen, representing 9% of all new ophthalmic referrals during the study period. 26% were seen between 2 and 4 months after starting Fingolimod treatment, 74% between 3 and 4 months after starting Fingolimod treatment. The impact on clinical services is discussed.
authors.affiliation: University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Moosavi
authors.affiliation: University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Bremner
authors.affiliation: University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy.
authors.forename: J
authors.initials: J
authors.lastname: Acheson
keywords: Fingolimod; guidelines; macular oedema; screening.